Medtronic (MDT) Cash from Operations (2014 - 2026)

Medtronic has disclosed Cash from Operations across 13 years of filings, most recently posting $1.8 billion for Q3 2026.

• In Q3 2026, Cash from Operations rose 64.8% year-over-year to $1.8 billion; the TTM figure through Jul 2026 stood at $8.0 billion (up 12.44% YoY), while the FY2026 annual figure was $7.3 billion, up 4.06% from the prior year.
• Cash from Operations came in at $1.8 billion for Q3 2026 at Medtronic, down from $2.6 billion in the prior quarter.
• In the past five years, Cash from Operations ranged from a high of $2.8 billion in Q2 2024 to a low of $661.0 million in Q4 2023.
• Average Cash from Operations over 5 years is $1.8 billion, with a median of $1.8 billion recorded in 2026.
• Year-over-year, Cash from Operations slumped 47.88% in 2022 and jumped 64.8% in 2026.
• Over 5 years, Cash from Operations stood at $922.0 million in 2022, then fell by 28.31% to $661.0 million in 2023, then jumped by 44.93% to $958.0 million in 2024, then retreated by 3.44% to $925.0 million in 2025, then soared by 93.84% to $1.8 billion in 2026.
• Per Business Quant data, the three most recent Cash from Operations figures were $1.8 billion in Q3 2026, $2.6 billion in Q2 2026, and $2.7 billion in Q1 2026.